Filed Pursuant to Rule 424(b)(5)
Registration No. 333-273707
Prospectus Supplement
(To Prospectus dated August 4, 2023)
$500,000,000
Common Stock
This prospectus supplement relates to the issuance and sale of shares of our common stock having an aggregate offering price of up to $500,000,000 from time to time through our sales agents, J.P. Morgan Securities LLC, Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, BMO Capital Markets Corp., TD Securities (USA) LLC and RBC Capital Markets, LLC. These sales, if any, will be made pursuant to the terms of an equity distribution agreement entered into between us and the sales agents on March 26, 2021, as amended by amendment no. 1 to the equity distribution agreement entered into on May 17, 2021 and amendment no. 2 to the equity distribution agreement entered into on August 4, 2023 (as amended, the “Equity Distribution Agreement”). In the event that we further amend the Equity Distribution Agreement to permit any sales agents other than J.P. Morgan Securities LLC, Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, BMO Capital Markets Corp., TD Securities (USA) LLC and RBC Capital Markets, LLC to become party to the Equity Distribution Agreement, we will file a prospectus supplement to reflect any additional sales agents.
We have sold shares of our common stock having an aggregate offering price of $348,301,440 as of the date of this prospectus supplement, pursuant to the Equity Distribution Agreement, a registration statement on Form S-3 (File No. 333-240975) filed on August 5, 2020 and a prospectus supplement dated March 26, 2021, as supplemented by supplement no. 1 dated May 17, 2021. Accordingly, as of the date of this prospectus supplement, shares of our common stock having an aggregate offering price of $151,698,560 remain available for offer and sale pursuant to the Equity Distribution Agreement and this prospectus supplement.
Sales of shares of our common stock under this prospectus supplement, if any, may be made in privately negotiated transactions and/or any other method permitted by law, including block trades or sales deemed to be an “at the market” offering as defined in Rule 415 under the Securities Act of 1933, as amended (the “Securities Act”), which includes sales made directly on the New York Stock Exchange (the “NYSE”), sales made to or through a market maker other than on an exchange or sales through an electronic communications network. Each of the sales agents will make all sales using its commercially reasonable efforts consistent with its normal trading and sales practices on mutually agreed terms between the sales agents and us.
Our common stock trades on the NYSE under the symbol “MAC.” On August 3, 2023, the last reported sale price of our common stock on the NYSE was $12.59 per share.
We will pay each sales agent a commission that will not exceed, but may be lower than, 2.1% of the gross proceeds of the shares sold pursuant to the Equity Distribution Agreement by such sales agent. The net proceeds from any sales under this prospectus supplement will be used as described under “Use of Proceeds” in this prospectus supplement.
In connection with the sale of common stock on our behalf, the sales agents may be deemed to be an “underwriter” within the meaning of the Securities Act and the compensation of the sales agents may be deemed to be underwriting commissions or discounts. We have agreed to provide indemnification and contribution to the sales agents against certain liabilities, including liabilities under the Securities Act.
Investing in our common stock involves risks. See “Risk Factors” beginning on page S-3.
Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of these securities or passed on the adequacy or accuracy of prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.
| | | | | | | | | | |
J.P. Morgan | | Deutsche Bank Securities | | Goldman Sachs & Co. LLC | | BMO Capital Markets | | TD Securities | | RBC Capital Markets |
The date of this prospectus supplement is August 4, 2023.